We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$216M
AUM Growth
+$40.9M
Cap. Flow
+$30.7M
Cap. Flow %
14.18%
Top 10 Hldgs %
40.9%
Holding
110
New
40
Increased
20
Reduced
11
Closed
36

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.41M
2
BIIB icon
Biogen
BIIB
+$4.44M
3
CI icon
Cigna
CI
+$3.91M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$3.61M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$3.18M

Top Sells

Rank Stock Value
1
ARTC
ARTHROCARE CORP
ARTC
+$3.56M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$3.4M
3
GILD icon
Gilead Sciences
GILD
+$2.74M
4
ITMN
INTERMUNE INC
ITMN
+$2.21M
5
DXCM icon
DexCom
DXCM
+$2.13M

Sector Composition

Rank Sector Weight
1 Healthcare 64.65%
2 Industrials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUWE icon
51
Nuwellis
NUWE
$525K
– –
0
– –
INSM icon
52
CALL
Insmed
INSM
$29.5B
$1.14M 0.53%
+60,000
New +$1.14M
CTRX
53
PUT
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$1.12M 0.52%
+25,000
New +$1.2M
GILD icon
54
CALL
Gilead Sciences
GILD
$169B
$1.06M 0.49%
+15,000
New +$1.18M
PCYC
55
PUT
DELISTED
PHARMACYCLICS INC
PCYC
$1M 0.46%
+10,000
New +$1.3M
PRTA icon
56
Prothena Corp
PRTA
$469M
$958K 0.44%
+25,000
New +$806K
BGMS
57
Bio Green Med Solution Inc
BGMS
$5.24M
– –
0
– –
AVNR
58
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$918K 0.42%
250,000
-150,000
-38% -$572K
DYAX
59
DELISTED
DYAX CORPORATION
DYAX
$898K 0.42%
+100,000
New +$909K
SUPN icon
60
Supernus Pharmaceuticals
SUPN
$2.76B
$894K 0.41%
+100,000
New +$921K
CLDX icon
61
CALL
Celldex Therapeutics
CLDX
$3.45B
$884K 0.41%
3,333
– –
HOLX
62
CALL
DELISTED
Hologic
HOLX
$860K 0.4%
+40,000
New +$863K
AKAO
63
DELISTED
Achaogen Inc
AKAO
$851K 0.39%
+55,000
New +$951K
OPCH icon
64
CALL
Option Care Health
OPCH
$3.55B
$698K 0.32%
+25,000
New +$772K
EPZM
65
CALL
DELISTED
Epizyme, Inc
EPZM
$683K 0.32%
+30,000
New +$909K
SRNE
66
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$641K 0.3%
+50,000
New +$553K
RXDX
67
DELISTED
Ignyta, Inc.
RXDX
$530K 0.25%
+63,833
New +$598K
ARTC
68
CALL
DELISTED
ARTHROCARE CORP
ARTC
$482K 0.22%
10,000
-90,000
-90% -$4.27M
ZGNX
69
DELISTED
Zogenix, Inc.
ZGNX
$427K 0.2%
18,750
-12,500
-40% -$407K
MNTA
70
PUT
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$378K 0.17%
+32,500
New +$550K
SVRA icon
71
Savara
SVRA
$1.14B
$340K 0.16%
+7,143
New +$391K
MBOT icon
72
Microbot Medical
MBOT
$117M
$335K 0.15%
154
-93
-38% -$222K
FMI
73
PUT
DELISTED
Foundation Medicine, Inc.
FMI
$324K 0.15%
+10,000
New +$325K
HZNP
74
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$227K 0.1%
+15,000
New +$169K
A icon
75
Agilent Technologies
A
$42B
– –
-34,950
Closed -$1.43M
1 2
3
4 5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2014 Portfolio in Review

As of Q1 2014, Iguana Healthcare Management held 110 positions worth $216M, up 23% from $175M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Iguana Healthcare Management deployed $30.7M of net new capital in Q1 2014, opening 40 new positions and adding to 20 existing holdings. Its largest new stake was Medtronic: 110,000 shares worth $6.77M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 61% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.74M trimmed.

  • Iguana Healthcare Management's largest Q1 2014 buy was Medtronic: 110,000 shares worth $6.77M.
  • Iguana Healthcare Management added most to Biogen in Q1 2014, an estimated $4.44M increase.
  • Iguana Healthcare Management's biggest Q1 2014 reduction was Gilead Sciences, cutting an estimated $2.74M.
  • Iguana Healthcare Management fully exited ARTHROCARE CORP in Q1 2014, selling an estimated $3.56M.
  • Iguana Healthcare Management's ten largest holdings make up 41% of its $216M portfolio in Q1 2014.
  • Iguana Healthcare Management opened 40 new positions and closed 36 in Q1 2014.
  • Iguana Healthcare Management's portfolio value rose 23% quarter-over-quarter to $216M.

Based on Iguana Healthcare Management's 13F filing for Q1 2014, filed 16 May 2014.